Fair Value of Financial Liabilities Recorded at Amortized Cost |
Fair Value of Financial Liabilities Recorded at Amortized Cost The following tables present the carrying amounts and fair values of the Registrants’ short-term liabilities, long-term debt, and trust preferred securities (long-term debt to financing trusts or junior subordinated debentures) as of June 30, 2025 and December 31, 2024. The Registrants have no financial liabilities measured using the NAV practical expedient. The carrying amounts of the Registrants’ short-term liabilities as presented in their Consolidated Balance Sheets are representative of their fair value (Level 2) because of the short-term nature of these instruments. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2025 | | December 31, 2024 | | | Carrying Amount | | Fair Value | | Carrying Amount | | Fair Value | | | | Level 1 | | Level 2 | | Level 3 | | Total | | | Level 1 | | Level 2 | | Level 3 | | Total | Long-Term Debt, including amounts due within one year(a) | Exelon | | $ | 47,345 | | | $ | — | | | $ | 38,504 | | | $ | 4,211 | | | $ | 42,715 | | | $ | 44,400 | | | $ | — | | | $ | 35,337 | | | $ | 3,720 | | | $ | 39,057 | | ComEd | | 12,750 | | | — | | | 11,157 | | | — | | | 11,157 | | | 12,030 | | | — | | | 10,260 | | | — | | | 10,260 | | PECO | | 5,705 | | | — | | | 4,852 | | | — | | | 4,852 | | | 5,704 | | | — | | | 4,816 | | | — | | | 4,816 | | BGE | | 6,040 | | | — | | | 5,435 | | | — | | | 5,435 | | | 5,395 | | | — | | | 4,702 | | | — | | | 4,702 | | PHI | | 9,535 | | | — | | | 4,182 | | | 4,211 | | | 8,393 | | | 9,124 | | | — | | | 4,093 | | | 3,720 | | | 7,813 | | Pepco | | 4,558 | | | — | | | 2,517 | | | 1,770 | | | 4,287 | | | 4,362 | | | — | | | 2,475 | | | 1,544 | | | 4,019 | | DPL | | 2,346 | | | — | | | 641 | | | 1,399 | | | 2,040 | | | 2,220 | | | — | | | 623 | | | 1,250 | | | 1,873 | | ACE | | 2,035 | | | — | | | 809 | | | 1,042 | | | 1,851 | | | 1,933 | | | — | | | 787 | | | 925 | | | 1,712 | | Long-Term Debt to Financing Trusts | Exelon | | $ | 390 | | | $ | — | | | $ | — | | | $ | 397 | | | $ | 397 | | | $ | 390 | | | $ | — | | | $ | — | | | $ | 396 | | | $ | 396 | | ComEd | | 206 | | | — | | | — | | | 210 | | | 210 | | | 206 | | | — | | | — | | | 208 | | | 208 | | PECO | | 184 | | | — | | | — | | | 186 | | | 186 | | | 184 | | | — | | | — | | | 188 | | | 188 | |
__________ (a)Includes unamortized debt issuance costs, unamortized debt discount and premium, net, purchase accounting fair value adjustments, and finance lease liabilities which are not fair valued. Refer to Note 16 — Debt and Credit Agreements of the 2024 Form 10-K for unamortized debt issuance costs, unamortized debt discount and premium, net, and purchase accounting fair value adjustments and Note 10 — Leases of the 2024 Form 10-K for finance lease liabilities.
|
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
Recurring Fair Value Measurements The following tables present assets and liabilities measured and recorded at fair value in the Registrants' Consolidated Balance Sheets on a recurring basis and their level within the fair value hierarchy at June 30, 2025 and December 31, 2024. Exelon and the Utility Registrants have immaterial and no financial assets or liabilities measured using the NAV practical expedient, respectively: Exelon | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | At June 30, 2025 | | At December 31, 2024 | | Level 1 | | Level 2 | | Level 3 | | | | Total | | Level 1 | | Level 2 | | Level 3 | | | | Total | Assets | | | | | | | | | | | | | | | | | | | | Cash equivalents(a) | $ | 926 | | | $ | — | | | $ | — | | | | | $ | 926 | | | $ | 544 | | | $ | — | | | $ | — | | | | | $ | 544 | | Rabbi trust investments | | | | | | | | | | | | | | | | | | | | Cash equivalents | 97 | | | — | | | — | | | | | 97 | | | 94 | | | — | | | — | | | | | 94 | | Mutual funds | 64 | | | — | | | — | | | | | 64 | | | 65 | | | — | | | — | | | | | 65 | | Fixed income | — | | | 6 | | | — | | | | | 6 | | | — | | | 6 | | | — | | | | | 6 | | Life insurance contracts | — | | | 71 | | | 23 | | | | | 94 | | | — | | | 73 | | | 22 | | | | | 95 | | Rabbi trust investments subtotal | 161 | | | 77 | | | 23 | | | | | 261 | | | 159 | | | 79 | | | 22 | | | | | 260 | | | | | | | | | | | | | | | | | | | | | | Interest rate derivative assets | | | | | | | | | | | | | | | | | | | | Derivatives designated as hedging instruments | — | | | 2 | | | — | | | | | 2 | | | — | | | 26 | | | — | | | | | 26 | | Economic hedges | — | | | — | | | — | | | | | — | | | — | | | — | | | — | | | | | — | | Interest rate derivative assets subtotal | — | | | 2 | | | — | | | | | 2 | | | — | | | 26 | | | — | | | | | 26 | | Total assets | 1,087 | | | 79 | | | 23 | | | | | 1,189 | | | 703 | | | 105 | | | 22 | | | | | 830 | | Liabilities | | | | | | | | | | | | | | | | | | | | Commodity derivative liabilities | — | | | — | | | (135) | | | | | (135) | | | — | | | — | | | (132) | | | | | (132) | | Interest rate derivative liabilities | | | | | | | | | | | | | | | | | | | | Derivatives designated as hedging instruments | — | | | (7) | | | — | | | | | (7) | | | — | | | (1) | | | — | | | | | (1) | | Economic hedges | — | | | — | | | — | | | | | — | | | — | | | — | | | — | | | | | — | | Interest rate derivative liabilities subtotal | — | | | (7) | | | — | | | | | (7) | | | — | | | (1) | | | — | | | | | (1) | | Deferred compensation obligation | — | | | (64) | | | — | | | | | (64) | | | — | | | (74) | | | — | | | | | (74) | | Total liabilities | — | | | (71) | | | (135) | | | | | (206) | | | — | | | (75) | | | (132) | | | | | (207) | | Total net assets (liabilities) | $ | 1,087 | | | $ | 8 | | | $ | (112) | | | | | $ | 983 | | | $ | 703 | | | $ | 30 | | | $ | (110) | | | | | $ | 623 | |
__________ (a)Exelon excludes cash of $150 million and $219 million at June 30, 2025 and December 31, 2024, respectively, and restricted cash of $175 million and $176 million at June 30, 2025 and December 31, 2024, respectively, and includes long-term restricted cash of $49 million and $41 million at June 30, 2025 and December 31, 2024, respectively, which is reported in Other deferred debits and other assets in the Consolidated Balance Sheets. ComEd, PECO, and BGE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ComEd | | PECO | | BGE | At June 30, 2025 | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | Assets | | | | | | | | | | | | | | | | | | | | | | | | Cash equivalents(a) | $ | 613 | | | $ | — | | | $ | — | | | $ | 613 | | | $ | 2 | | | $ | — | | | $ | — | | | $ | 2 | | | $ | 232 | | | $ | — | | | $ | — | | | $ | 232 | | Rabbi trust investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Mutual funds | — | | | — | | | — | | | — | | | 11 | | | — | | | — | | | 11 | | | 9 | | | — | | | — | | | 9 | | Life insurance contracts | — | | | — | | | — | | | — | | | — | | | 22 | | | — | | | 22 | | | — | | | — | | | — | | | — | | Rabbi trust investments subtotal | — | | | — | | | — | | | — | | | 11 | | | 22 | | | — | | | 33 | | | 9 | | | — | | | — | | | 9 | | | | | | | | | | | | | | | | | | | | | | | | | | Total assets | 613 | | | — | | | — | | | 613 | | | 13 | | | 22 | | | — | | | 35 | | | 241 | | | — | | | — | | | 241 | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | Commodity derivative liabilities(b) | — | | | — | | | (135) | | | (135) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | Deferred compensation obligation | — | | | (8) | | | — | | | (8) | | | — | | | (7) | | | — | | | (7) | | | — | | | (4) | | | — | | | (4) | | Total liabilities | — | | | (8) | | | (135) | | | (143) | | | — | | | (7) | | | — | | | (7) | | | — | | | (4) | | | — | | | (4) | | Total net assets (liabilities) | $ | 613 | | | $ | (8) | | | $ | (135) | | | $ | 470 | | | $ | 13 | | | $ | 15 | | | $ | — | | | $ | 28 | | | $ | 241 | | | $ | (4) | | | $ | — | | | $ | 237 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ComEd | | PECO | | BGE | At December 31, 2024 | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | Assets | | | | | | | | | | | | | | | | | | | | | | | | Cash equivalents(a) | $ | 390 | | | $ | — | | | $ | — | | | $ | 390 | | | $ | 29 | | | $ | — | | | $ | — | | | $ | 29 | | | $ | 1 | | | $ | — | | | $ | — | | | $ | 1 | | Rabbi trust investments | | | | | | | | | | | | | | | | | | | | | | | | Mutual funds | — | | | — | | | — | | | — | | | 12 | | | — | | | — | | | 12 | | | 10 | | | — | | | — | | | 10 | | Life insurance contracts | — | | | — | | | — | | | — | | | — | | | 22 | | | — | | | 22 | | | — | | | — | | | — | | | — | | Rabbi trust investments subtotal | — | | | — | | | — | | | — | | | 12 | | | 22 | | | — | | | 34 | | | 10 | | | — | | | — | | | 10 | | Total assets | 390 | | | — | | | — | | | 390 | | | 41 | | | 22 | | | — | | | 63 | | | 11 | | | — | | | — | | | 11 | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | Commodity derivative liabilities(b) | — | | | — | | | (132) | | | (132) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | Deferred compensation obligation | — | | | (8) | | | — | | | (8) | | | — | | | (7) | | | — | | | (7) | | | — | | | (4) | | | — | | | (4) | | Total liabilities | — | | | (8) | | | (132) | | | (140) | | | — | | | (7) | | | — | | | (7) | | | — | | | (4) | | | — | | | (4) | | Total net assets (liabilities) | $ | 390 | | | $ | (8) | | | $ | (132) | | | $ | 250 | | | $ | 41 | | | $ | 15 | | | $ | — | | | $ | 56 | | | $ | 11 | | | $ | (4) | | | $ | — | | | $ | 7 | |
__________ (a)ComEd excludes cash of $61 million and $66 million at June 30, 2025 and December 31, 2024, respectively, and restricted cash of $173 million and $176 million at June 30, 2025 and December 31, 2024, respectively. Additionally, ComEd includes long-term restricted cash of $49 million and $41 million at June 30, 2025 and December 31, 2024, respectively, which is reported in Other deferred debits and other assets in the Consolidated Balance Sheets. PECO excludes cash of $23 million and $19 million at June 30, 2025 and December 31, 2024, respectively. BGE excludes cash of $9 million and $33 million at June 30, 2025 and December 31, 2024, respectively. (b)The Level 3 balance consists of the current and noncurrent liability of $24 million and $111 million, respectively, at June 30, 2025 and $29 million and $103 million, respectively, at December 31, 2024 related to floating-to-fixed energy swap contracts with unaffiliated suppliers. PHI, Pepco, DPL, and ACE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | At June 30, 2025 | | At December 31, 2024 | PHI | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | Assets | | | | | | | | | | | | | | | | Cash equivalents(a) | $ | 47 | | | $ | — | | | $ | — | | | $ | 47 | | | $ | 93 | | | $ | — | | | $ | — | | | $ | 93 | | Rabbi trust investments | | | | | | | | | | | | | | | | Cash equivalents | 95 | | | — | | | — | | | 95 | | | 92 | | | — | | | — | | | 92 | | Mutual funds | 9 | | | — | | | — | | | 9 | | | 9 | | | — | | | — | | | 9 | | Fixed income | — | | | 6 | | | — | | | 6 | | | — | | | 6 | | | — | | | 6 | | Life insurance contracts | — | | | 21 | | | 22 | | | 43 | | | — | | | 23 | | | 21 | | | 44 | | Rabbi trust investments subtotal | 104 | | | 27 | | | 22 | | | 153 | | | 101 | | | 29 | | | 21 | | | 151 | | Total assets | 151 | | | 27 | | | 22 | | | 200 | | | 194 | | | 29 | | | 21 | | | 244 | | Liabilities | | | | | | | | | | | | | | | | Deferred compensation obligation | — | | | (10) | | | — | | | (10) | | | — | | | (12) | | | — | | | (12) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total liabilities | — | | | (10) | | | — | | | (10) | | | — | | | (12) | | | — | | | (12) | | Total net assets | $ | 151 | | | $ | 17 | | | $ | 22 | | | $ | 190 | | | $ | 194 | | | $ | 17 | | | $ | 21 | | | $ | 232 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Pepco | | DPL | | ACE | At June 30, 2025 | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | Assets | | | | | | | | | | | | | | | | | | | | | | | | Cash equivalents(a) | $ | 23 | | | $ | — | | | $ | — | | | $ | 23 | | | $ | 6 | | | $ | — | | | $ | — | | | $ | 6 | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Rabbi trust investments | | | | | | | | | | | | | | | | | | | | | | | | Cash equivalents | 94 | | | — | | | — | | | 94 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | Life insurance contracts | — | | | 21 | | | 22 | | | 43 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | Rabbi trust investments subtotal | 94 | | | 21 | | | 22 | | | 137 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | Total assets | 117 | | | 21 | | | 22 | | | 160 | | | 6 | | | — | | | — | | | 6 | | | — | | | — | | | — | | | — | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | Deferred compensation obligation | — | | | (1) | | | — | | | (1) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total liabilities | — | | | (1) | | | — | | | (1) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | Total net assets | $ | 117 | | | $ | 20 | | | $ | 22 | | | $ | 159 | | | $ | 6 | | | $ | — | | | $ | — | | | $ | 6 | | | $ | — | | | $ | — | | | $ | — | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Pepco | | DPL | | ACE | At December 31, 2024 | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | Assets | | | | | | | | | | | | | | | | | | | | | | | | Cash equivalents(a) | $ | 21 | | | $ | — | | | $ | — | | | $ | 21 | | | $ | 3 | | | $ | — | | | $ | — | | | $ | 3 | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | Rabbi trust investments | | | | | | | | | | | | | | | | | | | | | | | | Cash equivalents | 91 | | | — | | | — | | | 91 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Life insurance contracts | — | | | 23 | | | 21 | | | 44 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | Rabbi trust investments subtotal | 91 | | | 23 | | | 21 | | | 135 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | Total assets | 112 | | | 23 | | | 21 | | | 156 | | | 3 | | | — | | | — | | | 3 | | | — | | | — | | | — | | | — | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | Deferred compensation obligation | — | | | (1) | | | — | | | (1) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total liabilities | — | | | (1) | | | — | | | (1) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | Total net assets | $ | 112 | | | $ | 22 | | | $ | 21 | | | $ | 155 | | | $ | 3 | | | $ | — | | | $ | — | | | $ | 3 | | | $ | — | | | $ | — | | | $ | — | | | $ | — | |
__________ (a)PHI excludes cash of $48 million and $70 million at June 30, 2025 and December 31, 2024, respectively, and restricted cash of $2 million and zero at June 30, 2025 and December 31, 2024. Pepco excludes cash of $21 million and $30 million at June 30, 2025 and December 31, 2024, respectively. DPL excludes cash of $8 million and $20 million at June 30, 2025 and December 31, 2024, respectively. ACE excludes cash of $15 million and $14 million at June 30, 2025 and December 31, 2024, respectively and restricted cash of $2 million and zero at June 30, 2025 and December 31, 2024, respectively
|
Fair Value Reconciliation of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis |
Reconciliation of Level 3 Assets and Liabilities The following tables present the fair value reconciliation of Level 3 assets and liabilities measured at fair value on a recurring basis during the three and six months ended June 30, 2025 and 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Exelon | | ComEd | | PHI and Pepco | | | Three Months Ended June 30, 2025 | Total | | Commodity Derivatives | | Life Insurance Contracts | | | Balance at March 31, 2025 | $ | (129) | | | $ | (151) | | | $ | 21 | | | | Total realized / unrealized gains (losses) | | | | | | | | Included in net income(a) | 1 | | | — | | | 1 | | | | | | | | | | | | | | | | | | | | Included in regulatory assets/liabilities | 16 | | | 16 | | (b) | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Settlements | — | | | — | | | — | | | | | | | | | | | | | | | | | | | | Balance at June 30, 2025 | $ | (112) | | | $ | (135) | | (c) | $ | 22 | | | | The amount of total gains included in income attributed to the change in unrealized gains related to assets and liabilities at June 30, 2025 | $ | 1 | | | $ | — | | | $ | 1 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Exelon | | ComEd | | PHI and Pepco | | | Three Months Ended June 30, 2024 | Total | | Commodity Derivatives | | Life Insurance Contracts | | | Balance at March 31, 2024 | $ | (65) | | | $ | (108) | | | $ | 41 | | | | Total realized / unrealized gains (losses) | | | | | | | | Included in net income(a) | 1 | | | — | | | 2 | | | | | | | | | | | | Included in regulatory assets/liabilities | (31) | | | (31) | | (b) | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Settlements | (21) | | | — | | | (21) | | | | | | | | | | | | | | | | | | | | Balance at June 30, 2024 | $ | (116) | | | $ | (139) | | | $ | 22 | | | | The amount of total gains included in income attributed to the change in unrealized gains related to assets and liabilities at June 30, 2024 | $ | 2 | | | $ | — | | | $ | 2 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Exelon | | ComEd | | PHI and Pepco | | | Six Months Ended June 30, 2025 | Total | | Commodity Derivatives | | Life Insurance Contracts | | | Balance at December 31, 2024 | $ | (110) | | | $ | (132) | | | $ | 21 | | | | Total realized / unrealized gains (losses) | | | | | | | | Included in net income(a) | 1 | | | — | | | 1 | | | | | | | | | | | | | | | | | | | | Included in regulatory assets/liabilities | (3) | | | (3) | | (b) | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Settlements | — | | | — | | | — | | | | | | | | | | | | | | | | | | | | Balance at June 30, 2025 | $ | (112) | | | $ | (135) | | (c) | $ | 22 | | | | The amount of total gains included in income attributed to the change in unrealized gains related to assets and liabilities at June 30, 2025 | $ | 1 | | | $ | — | | | $ | 1 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Exelon | | ComEd | | PHI and Pepco | | | Six Months Ended June 30, 2024 | Total | | Commodity Derivatives | | Life Insurance Contracts | | | Balance at December 31, 2023 | $ | (90) | | | $ | (133) | | | $ | 41 | | | | Total realized / unrealized gains (losses) | | | | | | | | Included in net income(a) | 1 | | | — | | | 2 | | | | | | | | | | | | Included in regulatory assets/liabilities | (6) | | | (6) | | (b) | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Settlements | (21) | | | — | | | (21) | | | | | | | | | | | | | | | | | | | | Balance at June 30, 2024 | $ | (116) | | | $ | (139) | | | $ | 22 | | | | The amount of total gains included in income attributed to the change in unrealized gains related to assets and liabilities at June 30, 2024 | $ | 2 | | | $ | — | | | $ | 2 | | | | __________(a)Classified in Operating and maintenance expense in the Consolidated Statements of Operations and Comprehensive Income. (b)Includes $5 million of increases in fair value and an increase for realized gains due to settlements of $11 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the three months ended June 30, 2025. Includes $43 million of decreases in fair value and an increase for realized gains due to settlements of $12 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the three months ended June 30, 2024. Includes $17 million of decreases in fair value and an increase for realized gains due to settlements of $20 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the six months ended June 30, 2025. Includes $30 million of decreases in fair value and an increase for realized gains due to settlements of $24 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the six months ended June 30, 2024. (c)The balance of the current and noncurrent asset was effectively zero as of June 30, 2025. The balance consists of a current and noncurrent liability of $24 million and $111 million, respectively, as of June 30, 2025.
|